Provenienza dei contatti di primo grado di Kunihiko Ito
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Ono Pharma USA, Inc.
 Ono Pharma USA, Inc. Internet Software/ServicesTechnology Services Part of Ono Pharmaceutical Co., Ltd., Ono Pharma USA, Inc. operates as a pharmaceutical platform. The company is based in Cambridge, MA. The company was founded in 1998. The CEO is Kunihiko Ito.
2
| Subsidiary | Internet Software/Services | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kunihiko Ito tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ONO PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | President Private Equity Investor | |
| Kyoto University | College/University | Doctorate Degree Graduate Degree | |
| DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Mitobridge, Inc.
 Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| University of Tsukuba | College/University | Doctorate Degree | |
| McGill University | College/University | Masters Business Admin | |
Potenza Therapeutics, Inc.
 Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Astellas Venture Management LLC
 Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Ono Venture Investment, Inc.
 Ono Venture Investment, Inc. Investment ManagersFinance Ono Venture Investment Inc (Ono Venture Investment) is a venture capital arm of Ono Pharmaceutical Co Ltd. founded in 2020. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Pharmaceuticals: Major | Private Equity Investor |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Giappone | 4 |
| Canada | 2 |
Settori
| Health Technology | 6 |
| Consumer Services | 4 |
| Finance | 3 |
Posizioni
| Private Equity Investor | 5 |
| Director/Board Member | 4 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 2 |
| Chief Operating Officer | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Shunichiro Matsumoto | 10 |
| Toichi Takino | 4 |
- Borsa valori
- Insiders
- Kunihiko Ito
- Connessioni Società
